药易购完成管理层调整 持续强化企业内控

Core Viewpoint - The recent board restructuring at YaoYigou (300937) has sparked market interest, particularly with the appointment of Chen Shunjun as the new chairman, which raises expectations for the company's digital transformation achievements [1] Group 1: Leadership Changes - Chen Shunjun, born in 1977, has extensive experience in artificial intelligence, big data, and strategic planning, which is expected to enhance the company's digital transformation efforts [1] - The independent director team has been significantly adjusted, with three university professors joining, bringing expertise in accounting, law, and business, potentially broadening the company's strategic vision [1] - Wang Yadong has been appointed as the head of auditing, holding qualifications as a sponsor representative and a registered accountant, with prior experience in major financial institutions [1] Group 2: Audit Committee Expansion - The audit committee has been expanded from three to five members, now including Li Yanfei (director and actual controller), Zhao Peipei (employee representative director), and three independent directors, with Gan Shengdao serving as the chairman [2] Group 3: Internal Control and Financial Performance - YaoYigou has emphasized internal control, continuously improving its internal control systems and enhancing internal audit supervision to prevent fund misuse [3] - The company has reported stable revenue performance, with revenues exceeding 4 billion yuan in both 2023 and 2024 [4]